title: Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab.
authors.forename: Maria K
authors.initials: MK
authors.lastname: Angelopoulou
authors.forename: Gerassimos A
authors.initials: GA
authors.lastname: Pangalis
authors.forename: Sotirios
authors.initials: S
authors.lastname: Sachanas
authors.forename: Styliani I
authors.initials: SI
authors.lastname: Kokoris
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Anargyrou
authors.forename: Zaharoula
authors.initials: Z
authors.lastname: Galani
authors.forename: Christina
authors.initials: C
authors.lastname: Kalpadakis
authors.forename: Theodoros P
authors.initials: TP
authors.lastname: Vassilakopoulos
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use* / Q000633:toxicity; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab